SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018909
Filing Date
2023-11-14
Accepted
2023-11-14 07:00:49
Documents
107
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q jagx-20230930x10q.htm   iXBRL 10-Q 3588283
2 EX-31.1 jagx-20230930xex31d1.htm EX-31.1 11017
3 EX-31.2 jagx-20230930xex31d2.htm EX-31.2 11016
4 EX-32.1 jagx-20230930xex32d1.htm EX-32.1 6973
5 EX-32.2 jagx-20230930xex32d2.htm EX-32.2 6948
  Complete submission text file 0001558370-23-018909.txt   15117647

Data Files

Seq Description Document Type Size
6 EX-101.SCH jagx-20230930.xsd EX-101.SCH 108991
7 EX-101.CAL jagx-20230930_cal.xml EX-101.CAL 72248
8 EX-101.DEF jagx-20230930_def.xml EX-101.DEF 538576
9 EX-101.LAB jagx-20230930_lab.xml EX-101.LAB 800127
10 EX-101.PRE jagx-20230930_pre.xml EX-101.PRE 718190
101 EXTRACTED XBRL INSTANCE DOCUMENT jagx-20230930x10q_htm.xml XML 2802404
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 231401514
SIC: 2834 Pharmaceutical Preparations